Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
China Medical University Hospital
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants must be males or non-pregnant females at least 20 years of age.
Diagnosis of non-inflammatory breast adenocarcinoma or in situ breast cancer which were treated by operation with or without adjuvant or neoadjuvant hormonal treatment.
Patients were scheduled to receive five sessions of radiotherapy per week (1 session per day) for at least four weeks using standard irradiation fraction (with at least 1.8 Gy per session) for total dose of at least 45 Gy or hypofraction irradiation fraction(with 2.66 Gy per session) for total dose of at least 42.56 Gy.
Participant must give informed consent.
You may not be if
Bilateral breast cancer
Previous radiotherapy to the chest
Chemotherapy concurrent with radiation treatment
Prior breast reconstructions, implants, and/or expanders
Known radiosensitivity syndromes (e.g. Ataxia-telangiectasia)
Collagen vascular disease, vasculitis, unhealed surgical sites, breast infections or systemic lupus erythematosus (SLE)
Participation in any clinical trial in the prior 30 days from baseline.
Any condition that, in the judgement of the investigator could impose hazards to the patient if study therapy is initiated or affect the participation of the patient in the study.
Clareo Health | Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
